HK1158547A1 - Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use - Google Patents

Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Info

Publication number
HK1158547A1
HK1158547A1 HK11113241.7A HK11113241A HK1158547A1 HK 1158547 A1 HK1158547 A1 HK 1158547A1 HK 11113241 A HK11113241 A HK 11113241A HK 1158547 A1 HK1158547 A1 HK 1158547A1
Authority
HK
Hong Kong
Prior art keywords
kinin
corticosteroids
pharmaceutical compositions
receptor antagonists
compositions based
Prior art date
Application number
HK11113241.7A
Other languages
English (en)
Inventor
Sandro Giuliani
Carlo Alberto Maggi
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of HK1158547A1 publication Critical patent/HK1158547A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK11113241.7A 2008-07-11 2011-12-07 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use HK1158547A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2008A001264A IT1391236B1 (it) 2008-07-11 2008-07-11 Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso
PCT/EP2009/004847 WO2010003601A1 (en) 2008-07-11 2009-07-03 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Publications (1)

Publication Number Publication Date
HK1158547A1 true HK1158547A1 (en) 2012-07-20

Family

ID=40466843

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113241.7A HK1158547A1 (en) 2008-07-11 2011-12-07 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use

Country Status (36)

Country Link
US (1) US8476276B2 (xx)
EP (1) EP2303268B1 (xx)
JP (1) JP5791501B2 (xx)
KR (1) KR101656324B1 (xx)
CN (1) CN102088975B (xx)
AP (1) AP2803A (xx)
AR (1) AR072734A1 (xx)
AU (1) AU2009267416B2 (xx)
BR (1) BRPI0915866A2 (xx)
CA (1) CA2730420A1 (xx)
CO (1) CO6341556A2 (xx)
CR (1) CR20110021A (xx)
CY (1) CY1112900T1 (xx)
DK (1) DK2303268T3 (xx)
EA (1) EA019903B1 (xx)
EC (1) ECSP11010752A (xx)
ES (1) ES2389872T3 (xx)
GE (1) GEP20135792B (xx)
HK (1) HK1158547A1 (xx)
HN (1) HN2011000089A (xx)
HR (1) HRP20120678T1 (xx)
IL (1) IL210554A0 (xx)
IT (1) IT1391236B1 (xx)
MA (1) MA32542B1 (xx)
MX (1) MX2011000350A (xx)
MY (1) MY150477A (xx)
NI (1) NI201100014A (xx)
NZ (1) NZ590427A (xx)
PL (1) PL2303268T3 (xx)
PT (1) PT2303268E (xx)
RS (1) RS52418B (xx)
SI (1) SI2303268T1 (xx)
TW (1) TWI499419B (xx)
UA (1) UA100060C2 (xx)
WO (1) WO2010003601A1 (xx)
ZA (1) ZA201100287B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190653A1 (en) * 2011-01-20 2012-07-26 Dow Pharmaceutical Sciences, Inc. Therapeutic eye drop comprising doxycycline and a stabilizer
MX2015012650A (es) * 2013-03-14 2016-06-21 Shire Human Genetic Therapies Metodos para el tratamiento de angioedema mediado receptores debradicinina b2.
CN104072585A (zh) * 2014-07-21 2014-10-01 成都圣诺生物科技股份有限公司 一种合成艾替班特的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000696A1 (en) * 2001-06-26 2003-01-03 Metaphore Pharmaceuticals, Inc. COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
DE10304994A1 (de) * 2003-02-07 2004-09-02 Aventis Pharma Deutschland Gmbh Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"
EP1741444A1 (en) * 2005-07-05 2007-01-10 Jerini AG Kinin antagonists for treating bladder dysfunction
EP1894559A1 (en) * 2006-09-01 2008-03-05 PARI Pharma GmbH Means to solubilise steroids for inhalation

Also Published As

Publication number Publication date
KR20110044970A (ko) 2011-05-03
EP2303268B1 (en) 2012-06-20
HRP20120678T1 (hr) 2012-09-30
CR20110021A (es) 2011-07-11
MY150477A (en) 2014-01-30
ECSP11010752A (es) 2011-04-29
EA019903B1 (ru) 2014-07-30
UA100060C2 (uk) 2012-11-12
AR072734A1 (es) 2010-09-15
WO2010003601A1 (en) 2010-01-14
CA2730420A1 (en) 2010-01-14
AP2011005572A0 (en) 2011-02-28
IT1391236B1 (it) 2011-12-01
NZ590427A (en) 2012-09-28
CN102088975B (zh) 2013-08-21
NI201100014A (es) 2011-09-13
AU2009267416B2 (en) 2013-09-12
US20110112011A1 (en) 2011-05-12
RS52418B (en) 2013-02-28
JP5791501B2 (ja) 2015-10-07
EA201100013A1 (ru) 2011-08-30
TW201006471A (en) 2010-02-16
TWI499419B (zh) 2015-09-11
MX2011000350A (es) 2011-02-22
BRPI0915866A2 (pt) 2015-11-03
CO6341556A2 (es) 2011-11-21
ITMI20081264A1 (it) 2010-01-12
IL210554A0 (en) 2011-03-31
PL2303268T3 (pl) 2012-11-30
EP2303268A1 (en) 2011-04-06
KR101656324B1 (ko) 2016-09-09
AU2009267416A1 (en) 2010-01-14
HN2011000089A (es) 2013-01-28
GEP20135792B (en) 2013-03-25
JP2011527296A (ja) 2011-10-27
MA32542B1 (fr) 2011-08-01
AP2803A (en) 2013-11-30
US8476276B2 (en) 2013-07-02
SI2303268T1 (sl) 2012-10-30
ZA201100287B (en) 2012-03-28
PT2303268E (pt) 2012-09-24
ES2389872T3 (es) 2012-11-02
CY1112900T1 (el) 2016-04-13
DK2303268T3 (da) 2012-07-23
CN102088975A (zh) 2011-06-08
WO2010003601A8 (en) 2010-03-18

Similar Documents

Publication Publication Date Title
IL241632B (en) History of benzodiazepines, preparations containing them and their uses
EP2058304A4 (en) P2X4 RECEPTOR ANTAGONIST
EP2184278A4 (en) P2X4 RECEIVER ANTAGONIST
PL2259774T3 (pl) Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
IL210506A0 (en) Complement antagonists and uses thereof
EP2099454A4 (en) AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
HK1203980A1 (en) Il-17ra-il-17rb antagonists and uses thereof il-17ra-il-17rb
IL210185A0 (en) Methods, compositions and systems for local delivery of drugs
HK1136302A1 (en) Progesterone receptor antagonists
IL202752A0 (en) Il-23 receptor antagonists and uses thereof
EP2121658A4 (en) PIPERAZINYLPROPYLPYRAZOL DERIVATIVES AS DOPAMINE D4 RECEPTOR ANTAGONISTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ZA201001252B (en) Compositions and methods employing nmda antagonists for achieving an anesthetic-sparing effect
EP2480077A4 (en) Novel pyrrolidines as glucagonone receptor agonists, compositions thereof, and methods of use
SI2238110T1 (sl) Derivati 5,6-bisaril-2-piridin-karboksamida, njihova priprava in njihova terapevtska uporaba kot antagonisti receptorjev urotenzina II
IL213452A0 (en) Phenylpyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof
EP2365748A4 (en) IMIDAZOISOINDOLA ANTAGONISTS OF NEUROPEPTIDE S RECEPTORS
IL202996A0 (en) Anti-mcp-1 antibodies, compositions, methods and uses
IL207700A0 (en) 3-aminoalkyl-1,4-diazepan-2-one melanocortin -5 receptor antagonists
IL212171A (en) 1-Phenylpyrol compounds, pharmaceuticals containing them and their use
IL212170A (en) Mineral corticoid receptor antagonists, their atrophy isomers, their medicinal preparations and their use
HK1158547A1 (en) Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use
HK1146065A1 (en) Nlrr-1 antagonists and uses thereof nlrr-1
HUP0600925A3 (en) Dyaril-pyrazoles as cb1 antagonists, their use and pharmaceutical compositions containine them
GB0813395D0 (en) Local pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170703